1. Tkemaladze, Tinatin, Bratland, Eirik, Bregvadze, Kakha, Houge, Gunnar, Douzgou, Sofia. 2023. MSMO1 deficiency: a potentially partially treatable, ultrarare neurodevelopmental disorder with psoriasiform dermatitis, alopecia and polydactyly. In Clinical dysmorphology, 32, 97-105. doi:10.1097/MCD.0000000000000461. https://pubmed.ncbi.nlm.nih.gov/37195326/
2. Zheng, Guangfei, Wang, Zhuan, Fan, Yuchun, Chen, Su, Jiang, Lihe. 2021. The Clinical Significance and Immunization of MSMO1 in Cervical Squamous Cell Carcinoma Based on Bioinformatics Analysis. In Frontiers in genetics, 12, 705851. doi:10.3389/fgene.2021.705851. https://pubmed.ncbi.nlm.nih.gov/34759952/
3. Li, Ding, Wu, Xuan, Cheng, Cheng, Zhang, Wenzhou, Song, Wenping. 2023. A novel prognostic classification integrating lipid metabolism and immune co-related genes in acute myeloid leukemia. In Frontiers in immunology, 14, 1290968. doi:10.3389/fimmu.2023.1290968. https://pubmed.ncbi.nlm.nih.gov/38022627/
4. Liu, Manyu, Li, Jintao, Wang, Yangjunqi, Wang, Minglian, Li, Changshuo. 2022. MAGEA6 positively regulates MSMO1 and promotes the migration and invasion of oesophageal cancer cells. In Experimental and therapeutic medicine, 23, 204. doi:10.3892/etm.2022.11127. https://pubmed.ncbi.nlm.nih.gov/35126707/
5. Wang, Huiqing, Zhao, Mingpei, Chen, Guorong, Kang, Dezhi, Yu, Lianghong. 2024. Identifying MSMO1, ELOVL6, AACS, and CERS2 related to lipid metabolism as biomarkers of Parkinson's disease. In Scientific reports, 14, 17478. doi:10.1038/s41598-024-68585-3. https://pubmed.ncbi.nlm.nih.gov/39080336/
智鼠故事 
